Platinum Crosslinked Carbon Dot@TiO2−x p‐n Junctions for Relapse‐Free Sonodynamic Tumor Eradication via High‐Yield ROS and GSH Depletion
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Sonodynamic therapy as a promising noninvasive modality is being developed for tumor therapy, but there is a lack of next‐generation sonosensitizers that can generate full ROS at high yields and simultaneously deplete elevated levels of glutathione (GSH) in tumor cells. Semiconductor p‐n junctions are engineered as high‐efficacy sonosensitizers for sonodynamic tumor eradication using pyridine N‐doped carbon dots (N‐CDs) as a p‐type semiconductor and oxygen‐deficient TiO 2−x nanosheets as a n‐type semiconductor. The rate constants of 1 O 2 and •OH generation by ultrasound‐excited N‐CD@TiO 2−x p‐n junctions are 4.3 and 4.5 times higher than those of TiO 2, respectively. A Z‐scheme carrier migration mechanism in the p‐n junction achieving the rapid spatial separation of the ultrasound‐generated electron–hole pairs for enhanced full ROS production is proposed. GSH‐cleavable, Pt‐crosslinked, N‐doped CD fluorescent probes to detect the presence of intracellular GSH are also constructed. A GSH‐responsive, p‐n junction platform (Pt/N‐CD@TiO 2−x) with integrated GSH detection, GSH depletion, and enhanced sonodynamic performance is then assembled. Malignant tumors are completely eradicated without relapse via intravenous administration of low‐dose Pt/N‐CD@TiO 2−x under ultrasound irradiation. This work substantiates the great potential of biocompatible, GSH‐responsive p‐n junctions as next‐generation sonosensitizers via p‐n junction‐enhanced ROS generation and metal ion oxidation of intracellular GSH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Multifunctional sonosensitizers in sonodynamic cancer therapy
Son, S., Kim, J. H., Wang, X., Zhang, C., Yoon, S. A., Shin, J., Sharma, A., Lee, M. H., Cheng, L., Wu, J., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00648f · Cited by 1,150
Cited by
Nanozymes: Versatile Platforms for Cancer Diagnosis and Therapy
Zhang, X., Chen, X., & Zhao, Y. (2022) · Nano-Micro Letters · doi:10.1007/s40820-022-00828-2 · Cited by 304
Nano-ROS-generating approaches to cancer dynamic therapy: Lessons from nanoparticles
Zhang, Q., Luo, Q., Liu, Z., Sun, M., & Dong, X. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.141225 · Cited by 94
Luo, J., Cao, J., Ma, G., Wang, X., Sun, Y., Zhang, C., Shi, Z., Zeng, Y., Zhang, T., & Huang, P. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c08951 · Cited by 47
Wang, Y., Chang, F., Li, Y., Wang, F., Li, C., Li, H., & Jiang, Y. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2024.123046 · Cited by 26
Metadata
- Authors
- Geng, B., Xu, S., Li, P., Li, X., Fang, F., Pan, D., & Shen, L.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2021-12-02
- Volume
- 18
- Issue
- 6
- Pages
- e2103528-e2103528
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W3215917156
- Cited by
- 119
- References
- 4
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platinum Crosslinked Carbon Dot@TiO2−x p‐n Junctions for Relapse‐Free Sonodynamic Tumor Eradication via High‐Yield ROS and GSH Depletion. https://app.cochat.ai/papers/10.1002/smll.202103528
- The paper
- Geng, B., Xu, S., Li, P., Li, X., Fang, F., Pan, D., & Shen, L. (2022). Platinum Crosslinked Carbon Dot@TiO2−x p‐n Junctions for Relapse‐Free Sonodynamic Tumor Eradication via High‐Yield ROS and GSH Depletion. Small. https://doi.org/10.1002/smll.202103528
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.